TY - JOUR
T1 - Moderators of treatment response to exercise in participants with stimulant use disorder
T2 - Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study
AU - Rethorst, Chad D
AU - Henley, Steven S.
AU - Carmody, Thomas J.
AU - Cruz, Adriane dela
AU - Greer, Tracy L
AU - Walker, Robrina
AU - Stoutenberg, Mark
AU - Trivedi, Madhukar H.
N1 - Funding Information:
This research was made possible by grants from the National Institute on Drug Abuse ( NIDA ) of the National Institutes of Health , under Award Numbers R43DA047224 (PI: S.S. Henley), and U10DA020024 and UG1DA020024 (PI: M.H. Trivedi). This paper reflects the author's views and not necessarily the opinions or views of NIDA.
Funding Information:
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Greer has received contract research support from Janssen Research and Development LLC., grant funding from NARSAD, and consultant/honoraria for Lundbeck and Takeda. Dr. Trivedi has provided consulting services to Acadia Pharmaceuticals, Inc., Allergan, Inc., Alto Neuroscience Inc, Axsome Therapeutics, Engage Health Media, GreenLight VitalSign6 Inc, Janssen, Merck Sharp & Dohme Corp., Myriad Neuroscience, Navitor Pharmaceutical Inc, Otsuka, Perception Neuroscience, SAGE Therapeutics, and Signant Health. He has received grant/research funding from NIMH, NIDA, Patient-Centered Outcomes Research Institute (PCORI), and Cancer Prevention Research Institute of Texas (CPRIT). Additionally, he has received editorial compensation from Oxford University Press. Given their role as Editorial Board members, Rethorst C.D. and Trivedi M.H. had no involvement in the peer-review of this article and had no access to information regarding its peer-review.
Publisher Copyright:
© 2021
PY - 2021/10
Y1 - 2021/10
N2 - Exercise is a promising treatment for stimulant use disorder. However, efficacy has not been clearly demonstrated in a general stimulant using population where response to exercise is expected to be heterogeneous. Thus, examination of response heterogeneity to identify subgroups for whom exercise is either clearly indicated or not indicated is of considerable interest as findings will support more effective tailoring of patient treatments in practice and guide future research in stimulant use disorder. A secondary analysis of the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) randomized controlled trial of 302 stimulant using or dependent participants was conducted to identify baseline clinical and demographic characteristics associated with differential response between participants in the exercise and health education control groups. Characteristics (i.e., moderators of treatment response) were identified using an established Best Approximating Modeling (BAM) method. Six moderators of treatment response were identified: Quick Inventory of Depressive Symptomatology-Clinician (QIDS-C) rated total score, exercise test maximum systolic blood pressure, number of lifetime drug treatments, Stimulant Craving Questionnaire (STCQ) total score, Addiction Severity Index (ASI) Family subscale score, and Cognitive and Physical Functioning Questionnaire (CPFQ) total score. For all moderators, the odds ratio of response to exercise vs. health education ranged from 0.32 to 2.52 or more depending on the level of the moderator. These results demonstrate that it is possible to identify pre-treatment patient characteristics that predict statistically and clinically meaningful differential treatment response to exercise.
AB - Exercise is a promising treatment for stimulant use disorder. However, efficacy has not been clearly demonstrated in a general stimulant using population where response to exercise is expected to be heterogeneous. Thus, examination of response heterogeneity to identify subgroups for whom exercise is either clearly indicated or not indicated is of considerable interest as findings will support more effective tailoring of patient treatments in practice and guide future research in stimulant use disorder. A secondary analysis of the Stimulant Reduction Intervention using Dosed Exercise (STRIDE) randomized controlled trial of 302 stimulant using or dependent participants was conducted to identify baseline clinical and demographic characteristics associated with differential response between participants in the exercise and health education control groups. Characteristics (i.e., moderators of treatment response) were identified using an established Best Approximating Modeling (BAM) method. Six moderators of treatment response were identified: Quick Inventory of Depressive Symptomatology-Clinician (QIDS-C) rated total score, exercise test maximum systolic blood pressure, number of lifetime drug treatments, Stimulant Craving Questionnaire (STCQ) total score, Addiction Severity Index (ASI) Family subscale score, and Cognitive and Physical Functioning Questionnaire (CPFQ) total score. For all moderators, the odds ratio of response to exercise vs. health education ranged from 0.32 to 2.52 or more depending on the level of the moderator. These results demonstrate that it is possible to identify pre-treatment patient characteristics that predict statistically and clinically meaningful differential treatment response to exercise.
KW - Best approximating model
KW - Depression
KW - Exercise
KW - Moderator
KW - Stimulant use disorder
UR - http://www.scopus.com/inward/record.url?scp=85115653349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115653349&partnerID=8YFLogxK
U2 - 10.1016/j.mhpa.2021.100421
DO - 10.1016/j.mhpa.2021.100421
M3 - Article
AN - SCOPUS:85115653349
SN - 1755-2966
VL - 21
JO - Mental Health and Physical Activity
JF - Mental Health and Physical Activity
M1 - 100421
ER -